A Study Exploring the Safety, Tolerability, and Efficacy of a 28 Day Course Followed by an Additional 56 Day Course of Itacitinib in Subjects With Active Rheumatoid Arthritis A Study Exploring the Safety, Tolerability, and Efficacy of a 28 Day Course Followed by an Additiona ...
A Double- Blind, Placebo Controlled Study Exploring the Safety, Tolerability, and Efficacy of a 28 Day Course Followed by an Additional 56 Day Course of Itacitinib in Subjects With Active Rheumatoid Arthritis A Double- Blind, Placebo Controlled Study Exploring the Safety, Tolerability, and Efficacy of a 28 D ...